ENMD-2076 |
ENMD 981693 |
R-440 |
ENMD-981693 |
MKC-1 |
RO-317453 |
FDA Approval | not approved |
Drug Class | Small molecule |
Drug Indications | antineoplastic agent |
n/a |
Trial Name | MKC-1 |
Novel drug target | Novel Target |
n/a |
Trial Name | MKC-1 |
Novel drug target | Novel Target |
n/a |
Novel drug target | Novel Target |
Trial Name | MKC-1 |
n/a |
Trial Name | MKC-1 |
Novel drug target | Novel Target |
n/a |
Novel drug target | Novel Target |
Trial Name | MKC-1 |
n/a |
Novel drug target | Novel Target |
Trial Name | MKC-1 |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | SRC inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Fibroblast growth factor receptor inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | MKC-1 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Serine/threonine-protein kinase Aurora-A inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Fibroblast growth factor receptor inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | MKC-1 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Fibroblast growth factor receptor inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Platelet-derived growth factor receptor inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Platelet-derived growth factor receptor inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Tyrosine-protein kinase receptor FLT3 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Fibroblast growth factor receptor inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Vascular endothelial growth factor receptor 2 inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | SRC inhibitor |
Direct Interaction | yes |
Drug Indications | antineoplastic agent |
Drug Class | Small molecule |
FDA Approval | not approved |